Menstrual Migraine (MM)

Menstrual Migraine (MM) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Menstrual Migraine · Menstrual Migraines · Migraine;Menstrual
Classified under: Cardiovascular Diseases
Chemically-Induced Disorders
Mental Disorders
Sensation
Indicated drugs: Frovatriptan

Resolves to

Vocabularies

ICD-10G43SNOMED CT155046006MedDRA10027603UMLSC0149931

What you can answer from here — as of November 01, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

11Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Menstrual Migraine (MM) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.